Drug Approval | April 14, 2026
FDA fast-tracks Daiichi Sankyo & Merck lung cancer drug review
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
A brand from Opella will be part of the official NASA astronaut formulary
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
The company says the platform offers improved manufacturability and functional advantages
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
Subscribe To Our Newsletter & Stay Updated
